Updates are available Correction dated 2026-01-26
Click to view Correction: https://doi.org/10.1007/s00134-026-08316-6
-
Authors
Ichai, Carole https://orcid.org/0000-0002-0251-1280
Fontaine, Eric
Baumstarck, Karine
Rimmelé, Thomas
Strecker, Guillaume
Boucekine, Mohamed
Szabo, Vivien
Gosset, Clément
Heng, Anne-Elisabeth
Kerforne, Thomas
Naboulsi, Edouard
Velly, Lionel
Leone, Marc
Pottecher, Julien
Dépret, François
Margetis, Dimitri
Bouhemad, Bélaïd
Orban, Jean-Christophe
Leroy, Audrey
Riou, Bruno
Borao, Lucile
Constantin, Jean-Michel
,
Futier, Emmanuel
Escaravage, Laurence
Mousson, Christiane
Prin, Sébastien
Hazzan, Marc
Morelon, Emmanuel
Grégoire, Arnaud
Moal, Valérie
Lambert, Dominique
Meyer, Lara
Chalard, Kévin
Ashenoune, Karim
Giral, Magali
Martin-Lefèvre, Laurent
Leroy, Audrey
Muller, Laurent
Margetis, Dimitri
Drouin, Sarah
Legendre, Christophe
Rondeau, Eric
Plaud, Benoît
Brouta, Josée
Thierry, Antoine
Bernard, Thierry
Caillard-Ohlmann, Sophie
Lebas, Benjamin
Geeraerts, Thomas
Kamar, Nassim
Ducos, Guillaume
-
Funding
Funding for this research was provided by:
French Ministry of health (PHRC-N)
French Ministry of health (2016 AOM 15-296)
- License Information
-
More Information
Article History
Received: 30 August 2025
Accepted: 12 December 2025
First Online: 8 January 2026
Change Date: 25 January 2026
Change Type: Update
Change Details: The original online version of this article was revised: a co-author was added as 18th author.
Change Date: 26 January 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00134-026-08316-6
Declarations
:
: Dr Leone reported receiving consultancy fees from Previa and Biomerieux and payment as a speaker from AOP Pharma, Viatris, Shinogi and Grifol, all outside the submitted work. Dr Constantin reported receiving consultancy fees from Viatis, Amomed, Sedana, Aspen and payment as speaker Shinogi, Gilead, Aspen, Fischer-Payckel, Dräger and Sedana, all outside the submitted work. All other authors declare no relevant conflict of interest.
: The study was conducted in accordance with the Declaration of Helsinki and with local regulations. The study was registered at ClinicalTrials.gov (NCT02907554) before the first patient was enrolled. The study protocol received approval from the ethics committee for human research for all participating centers (Comité de Protection des Personnes Sud Est VI, ID-RCB 2014-003544-12) on April 23, 2015.
